FlynnTWPevonkaP.YostRLWeberCEStewartRB. Use of serum gentamicin levers in hospitalized patients. Am J Hosp Pharm1978; 35: 806–8.
5.
GentrySMKeithTDMcMillanDMGoetterWE. Evaluation of the ordering of serum theophylline concentrations. Am J Hosp Pharm1981; 38: 1937–9.
6.
WilsonJTWilkinsonGR. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analysis. Neurology1974; 24: 614–23.
7.
TaylorJTMcLeanAJLeonardRG., Initial experience of clinical pharmacology and clinical pharmacy interactions in a clinical pharmacokinetics consultation service. J Clin Pharmacol1979; 19: 1–7.
8.
GreenlawCWBloughSSHaugenRK. Aminoglycoside serum assays restricted through a pharmacy program. Am J Hosp Pharm1979; 36: 1080–3.
9.
ElenbaasRMPayneWWBaumanJL. Influence of clinical pharmacist consultations on the use of drug blood level tests. Am J Hosp Pharm1980; 37: 61–4.
10.
BullishSJKelyWNMillerDETimmonsRG. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital. Am J Hosp Pharm1981; 38: 73–6.
11.
WhitingB.KelmanAWBrysonSM., Clinical pharmacokinetics: A comprehensive system for therapeutic drug monitoring and prescribing. Br Med J1984; 288: 541–5.
12.
BootmanJLWertheimerAIZaskeD.RowlachC.Individualizing gentamicin dosage regimens in burn patients with gram negative septicemia: A cost-benefit analysis. J Pharm Sci1979; 68: 267–72.
13.
FinnALTaylorWJKaneWJ. General principles: Practical applications of serum concentration monitoring. In: TaylorWJFinnAL, eds. Individualizing drug therapy: Practical applications of drug monitoring. New York: Gross, Townsend, Frank, Inc.1981: 1–30.
14.
PippengerCE. Basic guidelines for routine TDM. Syva Monit1979; 1: 1–4.
15.
PippingerceThe future role of the clinical laboratory. Therapeutic drug monitoring. Am J Med Tech1983; 49: 565–7.
16.
FinnALTaylorWJMooreAL. Pharmacotherapeutics for the family physician. Am Fam Physician1979; 7: 1–48.
17.
SohnD.The clinician-laboratory connection, the vital link. Ther Drug Monit1979; 1: 453–7.
18.
TaylorWJ. Pharmacokinetics. Am J Med Tech1983; 49: 557–63.
KellyWNGibsonGAMillerDE. Obtaining reimbursement for clinical pharmacokinetic monitoring. Am J Hosp Pharm1982; 39: 1662–5.
22.
MooreRATonniesRD. Aminoglycoside dosing service provided by baccalaureate-level pharmacists. Am J Hosp Pharm1984; 41: 98–105.
23.
RietschaWJHeisslerJFPaulsonJFStockmanRABessertJAMelbyMJ. Collaborative clinical pharmacokinetics service in a community hospital. Am J Hosp Pharm1984; 41: 473–7.
24.
LehmannCRLeonardCR. Effect of theophylline pharmacokinetic monitoring service on cost and quality of care. Am J Hosp Pharm1982; 39: 1656–61.
25.
GehlbachSHWilkinsonWEHammondWE., Improving drug prescribing in a primary care practice. Med Care1984; 22: 192–201.
26.
CasscellsW.SchoenbergerA.GraboysTB. Interpretation by physicians of clinical laboratory results. New Engl J Med1978; 299: 999–1001.
27.
BoguslaskiRCBurdJF. Analytical methods for therapeutic drug monitoring. Am J Med Tech1983; 49: 551–6.
28.
CarruthersSGFreemanDJKoeglerJC., Simplified liquid-chromatographic analysis for cyclosporin A and comparison with radioimmunoassay. Clin Chem1983; 29: 180–3.
29.
The College of American Pathologists, 7400 North Skokie Blvd, Skokie, IL 60076.
30.
SpeicherceSmithJW. Interpretive reporting in clinical pathology. JAMA1980; 243: 1556–60.
31.
SvirbelyJRSpeicherCE. The importance of requests and report forms in the interpretation of therapeutic drug monitoring. Ther Drug Monit1980; 2: 211–4.
32.
BorgaO.PiafskyKMNilsenOG. Plasma protein binding of basic drugs. 1. Selective displacement of basic drugs from 1 acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther1977; 22: 539.
33.
StargelWWRoeCRRoutledgePAShandDG. Importance of blood collection tubes in plasma lidocaine determinations. Clin Chem1979; 25: 617–9.
34.
DaviesM.MorganJRAnandC.Interactions of carbenicillin and ticarcillin with gentamicin. Antimicrob Agents Chemother1975; 7: 431–4.
35.
MurilloJ.StandifondHCSchrimpffSCTatonBA. Gentamicin and ticarcillin serum levels. JAMA1979; 241: 2401–3.
36.
EdwardsDJSchentagJJ. In vitro interactions between β-lactam antibiotics and tobramycin (letter). Clin Pharm1981; 27: 341.
37.
KoupJR. Direct linear plotting method for estimation of pharmacokinetic parameters. J Pharm Sci1981; 70: 1093–4.
38.
KoupJRBenjaminDR. Numerical integration simulation programs for the microcomputer. Ther Drug Monit1980; 2: 243–7.
39.
RobinsonJDLopezLMStewartWL. How to establish a pharmacokinetic consulting service for ambulatory patients. Am J Hosp Pharm1984; 41: 2048–56.
40.
SawchukRJZaskeDECipolleRJ., Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Therapeut1977; 21: 362.
41.
MungallD.MarshallJ.PennD., Individualizing theophylline therapy: The impact of clinical pharmacokinetics on patient outcomes. Ther Drug Monit1983; 5: 95.
42.
FrakesMEPepinS.GodesT., Reimbursable pharmacokinetic dosing services in long-term care facilities. Presented at the American Society of Consultant Pharmacists, 13th Annual Meeting, November 1982.